Letizia Gnetti
Parma, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 106 publications
A radiomic approach to non-invasively decode tumor immune microenvironmental features in surgically resected non-small cell lung cancer.
Journal: Tumori
Published: August 12, 2026
BRAF Fusion as Resistance Mechanism to Osimertinib in EGFR-Mutated NSCLC: A Case Report and Review of Literature.
Journal: JTO clinical and research reports
Published: February 26, 2025
Genomic and Transcriptomic Profiles in Smokers and Never-Smokers Lung Squamous Cell Carcinoma Patients.
Journal: Lung Cancer (Auckland, N.Z.)
Published: January 23, 2025
The prognostic value of the haemoglobin/red cell distribution width ratio in a cohort of pre-treated patients with renal cell carcinoma receiving nivolumab.
Journal: Cancer treatment and research communications
Published: November 10, 2024
Onset of ANCA-positive EGPA with bilateral pleural effusion: a case report.
Journal: Current medical research and opinion
Published: November 08, 2024
Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy.
Journal: Cancer discovery
Published: October 18, 2024
Combined standard immunosuppression and immune checkpoint inhibition for BKPyV+ metastatic renal cell carcinoma of the graft in a kidney transplant recipient with chronic rejection: a case report.
Journal: Frontiers in oncology
Published: October 04, 2024
Correction to: Plasma exchange-sensitive syncytial glomerulopathy in a kidney transplant patient.
Journal: Virchows Archiv : an international journal of pathology
Published: August 30, 2024
MET alterations as resistance mechanisms of dabrafenib-trametinib in BRAF p.V600E mutated non-small cell lung cancer patient.
Journal: Anti-cancer drugs
Published: August 08, 2024
Editorial: Advances in molecular biology knowledge of rectal cancer and forthcoming role of liquid biopsy.
Journal: Frontiers in oncology
Published: August 05, 2024
CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase.
Journal: International journal of molecular sciences
Published: July 09, 2024
Last Updated: 09/26/2026